Full Press Release Details
dupixent dupilumab approved in the u s as the only targeted medicine to treat patients with bullous pemphigoid bp.
REGN
dupixent dupilumab approved in the u s as the only targeted medicine to treat patients with bullous pemphigoid bp
Key Takeaway: dupixent dupilumab approved in the u s as the only targeted medicine to treat patients with bullous pemphigoid bp